SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-013943
Filing Date
2017-02-23
Accepted
2017-02-23 17:39:53
Documents
2
Period of Report
2017-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6112
2 POA DOCUMENT poa.txt EX-24.4_705236 3540
  Complete submission text file 0001209191-17-013943.txt   11119
Mailing Address C/O CERUS CORPORATION 2411 STANWELL DRIVE CONCORD CA 94520
Business Address
DAWSON WILLIAM J (Reporting) CIK: 0001226139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 17633894

Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations